{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:26:34Z","timestamp":1790868394047,"version":"4.1.0"},"reference-count":74,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2015,6]]},"abstract":"<jats:p>Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of different specialists for proper treatment and genetic counseling, especially in NF2 and SCH. The present text suggests guidelines for the clinical management of NF, with emphasis on NF1.<\/jats:p>","DOI":"10.1590\/0004-282x20150042","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T23:05:17Z","timestamp":1433977517000},"page":"531-543","source":"Crossref","is-referenced-by-count":13,"title":["Neurofibromatosis: part 2 \u2013 clinical management"],"prefix":"10.1590","volume":"73","author":[{"given":"Pollyanna Barros","family":"Batista","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eny Maria Goloni","family":"Bertollo","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle de Souza","family":"Costa","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Eliam","sequence":"additional","affiliation":[{"name":"Radiologia Anchieta, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Soares Gon\u00e7alves","family":"Cunha","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Renan","family":"Cunha-Melo","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Guilherme","family":"Darrigo Junior","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Geller","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Faria","family":"Gianordoli-Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Gon\u00e7alves","family":"Madeira","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9rika Martins","family":"Mendes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Marques de","family":"Miranda","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas Andre","family":"Mata-Machado","sequence":"additional","affiliation":[{"name":"Loyola University of Chicago, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Grossi","family":"Morato","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rika Cristina","family":"Pavarino","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de S\u00e3o Jos\u00e9 do Rio Preto, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Baptista","family":"Pereira","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton Alves de","family":"Rezende","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edza de Oliveira","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Bezerra Cavalcanti","family":"Sette","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Menezes da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Ferreira de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Leandro Ribeiro de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Stangherlin","family":"Martins","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00eania Ribeiro","family":"Valadares","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Vieira Teixeira","family":"Vidigal","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Waisberg","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Waisberg","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Oswaldo Carneiro","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/0004-282X20130241","article-title":"Neurofibromatosess: part 1- diagnosis and differential diagnosis","volume":"72","author":"Rodrigues LO","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"ref2","series-title":"Neurofibromatosis: phenotype, natural history, and pathogenesis","first-page":"29","volume-title":"Clinical and epidemiological features","author":"Friedman J","year":"1999","edition":"3rd"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/bdra.20616","article-title":"Neurofibromatosis type 1 is a disorder of dysplasia: the importance of distinguishing features, consequences and complications","volume":"88","author":"Riccardi VM","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM198604173141603","article-title":"Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms","volume":"314","author":"S\u00f8rensen SA","year":"1986","journal-title":"N Engl J Med"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","article-title":"Mortality in neurofibromatosis 1 in North West England: an assessment of actuarial survival in a region of the UK since 1989","volume":"19","author":"Evans DG","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen SA","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-6-11","article-title":"Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006)","volume":"6","author":"Masocco M","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrclinonc.2013.144","article-title":"Advances in the treatment of neurofibromatosis-associated tumours","volume":"10","author":"Lin AL","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","article-title":"Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force","volume":"4","author":"Friedman JM","year":"2002","journal-title":"Genet Med"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jvs.2007.03.055","article-title":"Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results","volume":"46","author":"Oderich GS","year":"2007","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-13-18","article-title":"Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study","volume":"13","author":"Rodrigues LO","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1590\/S0104-42302009000400012","article-title":"Neurofibromatose tipo 1: mais comum e grave do que se imagina","volume":"55","author":"Souza JF","year":"2009","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2010.206532","article-title":"The neurofibromatosis","volume":"10","author":"Ferner RE","year":"2010","journal-title":"Pract Neurol"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jcp.56.10.758","article-title":"Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1","volume":"56","author":"Cunha KS","year":"2003","journal-title":"J Clin Pathol"},{"key":"ref16","series-title":"Neurofibromatosis: a handbook for patients, families, and health care professionals","author":"Korf BR","year":"2005","edition":"2th"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans DG","year":"2002","journal-title":"J Med Genet"},{"issue":"1","key":"ref18","article-title":"Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors","volume":"11","author":"Park SJ","year":"2013","journal-title":"BMC Med"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg M","year":"2013","journal-title":"Neuro-oncol"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.6061\/clinics\/2012(08)18","article-title":"Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival","volume":"67","author":"Cunha KS","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"ref21","series-title":"Neurofibromatosis in clinical practice","volume-title":"Neurofibromatosis 1","author":"Ferner RE","year":"2011"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00431-013-2035-2","article-title":"Ophthalmological assessment of children with neurofibromatosis type 1","volume":"172","author":"Cassiman C","year":"2013","journal-title":"Eur J Pediatr"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N","article-title":"Associations of clinical features in neurofibromatosis1 (NF1)","volume":"19","author":"Szudek J","year":"2000","journal-title":"Genet Epidemiol"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman SL","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.braindev.2009.12.008","article-title":"Behavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological level","volume":"33","author":"Hachon C","year":"2011","journal-title":"Brain Dev"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen A","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmg.2014.02.004","article-title":"Neuropsychological impairments in elderly Neurofibromatosis type 1 patients","volume":"57","author":"Costa DS","year":"2014","journal-title":"Eur J Med Genet"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S0012162201001876","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"44","author":"Mautner VF","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","article-title":"Neurofibromatosis type 1: from genotype to phenotype","volume":"49","author":"Pasmant E","year":"2012","journal-title":"J Med Genet"},{"issue":"29","key":"ref30","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1004829107","article-title":"Neurofibromin regulates corticostriatal inhibitory networks during working memory performance","volume":"107","author":"Shilyansky C","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.48.4.1121","article-title":"Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force","volume":"48","author":"North KN","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2011.06.016","article-title":"Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: Phase I study","volume":"45","author":"Acosta MT","year":"2011","journal-title":"Ped Neurol"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/ajmg.a.34314","article-title":"Objective assessment of nasality in Flemish adults with neurofibromatosis type 1","volume":"155A","author":"Cosyns M","year":"2011","journal-title":"Am J Med Genet"},{"issue":"3-4","key":"ref34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0911-6044(99)00012-3","article-title":"The nature of speech and language impairment in adults with neurofibromatosis1","volume":"12","author":"Lorch M","year":"1999","journal-title":"J Neurolinguist"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcomdis.2013.12.002","article-title":"Auditory temporal processing deficits and language disorders in patients with neurofibromatosis type 1","volume":"48","author":"Batista PB","year":"2014","journal-title":"J Commun Disord"},{"key":"ref36","author":"Silva CM","year":"2014"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1096-8628(20000717)93:2<136::AID-AJMG11>3.0.CO;2-L","article-title":"Parents\u2019 responses to their child\u2019s diagnosis of neurofibromatosis 1","volume":"93","author":"Ablon J","year":"2000","journal-title":"Am J Med Genet"},{"issue":"8","key":"ref38","first-page":"2359","article-title":"Social representations of patients and relatives regarding type 1 neurofibromatosis","volume":"18","author":"Cerello AC","year":"2013","journal-title":"Cien Saude Colet"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","author":"Stevenson DA","year":"2007","journal-title":"J Pediatr"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmg.2006.041095","article-title":"Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1","volume":"43","author":"Lammert M","year":"2006","journal-title":"J Med Genet"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-011-1191-3","article-title":"Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease)","volume":"304","author":"Petramala L","year":"2012","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1590\/S0100-879X2005000900020","article-title":"High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1","volume":"38","author":"Trov\u00f3-Marqui AB","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ocl.2007.03.008","article-title":"Scoliosis associated with neurofibromatosis","volume":"38","author":"Crawford AH","year":"2007","journal-title":"Orthop Clin North Am"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00586-004-0829-7","article-title":"Spinal deformity in neurofibromatosis type-1: diagnosis and treatment","volume":"14","author":"Tsirikos AI","year":"2005","journal-title":"Eur Spine J"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.rct.0000163705.21892.23","article-title":"Neurofibromatosis type 1: spinal manifestations of a systemic disease","volume":"29","author":"Restrepo CS","year":"2005","journal-title":"J Comput Assist Tomogr"},{"key":"ref46","series-title":"Physical activity and health: a report of the surgeon general","year":"1996"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1359786810382057","article-title":"Mortality trends in the general population: the importance of cardiorespiratory fitness","volume":"24","author":"Lee DC","year":"2010","journal-title":"J Psychopharmacol"},{"key":"ref48","series-title":"Physical activity, fitness, and health: international proceedings and consensus statement","first-page":"77","volume-title":"Physical activity, fitness, and health: the model and key concepts","author":"Bouchard C","year":"1994"},{"issue":"1","key":"ref49","first-page":"15","article-title":"Muscular force is reduced in neurofibromatosis type 1","volume":"9","author":"Souza JF","year":"2009","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.a.35729","article-title":"Exercise capacity impairment in individuals with neurofibromatosis type 1","volume":"161A","author":"Souza JF","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0030-4220(88)90252-6","article-title":"Jaw and skull changes in neurofibromatosis","volume":"66","author":"D\u2019Ambrosio JA","year":"1988","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0030-4220(84)90350-5","article-title":"Neurofibromatosis: oral andradiographic manifestations","volume":"58","author":"Shapiro SD","year":"1984","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bdj.4811175","article-title":"Neurofibromatosis type I with periodontal manifestation. A case report and literature review","volume":"196","author":"Cunha KS","year":"2004","journal-title":"Br Dent J"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00784-011-0519-x","article-title":"Oral soft tissue alterations in patients with neurofibromatosis","volume":"16","author":"Jouhilahti EM","year":"2012","journal-title":"Clin Oral Investig"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1010-5182(02)00160-9","article-title":"Jaw malformations plus displacement and numerical aberrations of teeth in neurofibromatosis type 1: a descriptive analysis of 48 patients based on panoramic radiographs and oral findings","volume":"31","author":"Friedrich RE","year":"2003","journal-title":"J Craniomaxillofac Surg"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<224::AID-AJMG12>3.0.CO;2-J","article-title":"Growth charts for young children with neurofibromatosis 1 (NF1)","volume":"92","author":"Szudek J","year":"2000","journal-title":"Am J Med Genet"},{"issue":"9840","key":"ref57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(12)60815-0","article-title":"Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study","volume":"380","author":"Pearce MS","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","article-title":"18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study","volume":"19","author":"Ferner RE","year":"2008","journal-title":"Ann Oncol"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00247-007-0712-x","article-title":"Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1","volume":"38","author":"Ferraz Filho JRL","year":"2008","journal-title":"Pediatr Radiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/B978-0-444-52902-2.00054-0","article-title":"Neurofibromatosis type 2 (NF2): diagnosis and management","volume":"115","author":"Lloyd SK","year":"2013","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5935\/1808-8694.20120020","article-title":"Neurofibromatosis 2: hearing restoration options","volume":"78","author":"Monteiro TA","year":"2012","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","article-title":"Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2","volume":"141","author":"Bosch MM","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1212\/01.WNL.0000163982.78900.AD","article-title":"Diagnostic criteria for schwannomatosis","volume":"64","author":"MacCollin M","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"ref64","first-page":"462","article-title":"Schwannomatose: primeiros casos relatados no Brasil","volume":"23","author":"Vilela S","year":"2013","journal-title":"Rev Med Minas Gerais"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen CM","year":"2008","journal-title":"Curr Biol"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-07-5916","article-title":"Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus B","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ijc.24783","article-title":"Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft","volume":"126","author":"Bhola P","year":"2010","journal-title":"Int J Cancer"},{"issue":"10","key":"ref68","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm SM","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pbc.23015","article-title":"Preclincial testing of sorafenib and RAD001 in the Nf(flox\/flox); DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging","volume":"58","author":"Wu J","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/pbc.24281","article-title":"Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas","volume":"60","author":"Kim A","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"ref71","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis MA","year":"2012","journal-title":"Neuro Oncol"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/00005537-200312000-00014","article-title":"Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate","volume":"113","author":"Cay\u00e9-Thomasen P","year":"2003","journal-title":"Laryngoscope"},{"issue":"6","key":"ref73","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","article-title":"Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients","volume":"33","author":"Plotkin SR","year":"2012","journal-title":"Otol Neurotol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.a.34359","article-title":"Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2","volume":"158A","author":"Blakeley JO","year":"2012","journal-title":"Amer J Medl Genetics"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v73n6\/0004-282X-anp-73-6-0531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T12:25:28Z","timestamp":1717935928000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2015000600531&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0004-282X2015000600531"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20150042","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}